OTC drugs
are medications that do not require a prescription. In contrast, prescription
drugs can be sold only to consumers having a legal prescription. OTC drugs are
carefully chosen by regulatory agencies to ensure their safety and efficacy.
Gastrointestinal OTC drugs can be bought off-the-shelf. Gastrointestinal OTC
drugs are used for indications such as GERD, vomiting, constipation, diarrhea,
and flatulence. Some of the OTC drugs that are available for the treatment of
gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists,
anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by
regulatory guidelines, but need to comply with the drug monograph of a country.
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/46752-global-gastrointestinal-otc-drugs-market-2015-2019
Technavio's
analysts forecast the global gastrointestinal OTC drugs market to grow at a
CAGR of 1.48% over the period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the global gastrointestinal OTC drugs market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of various OTC drugs available in the market for the management of gastrointestinal disorders such as:
• GERD/Heartburn
• Constipation
• Diarrhea
• Nausea due to motion sickness
• Flatulence .
Covered in this report
This report covers the present scenario and the growth prospects of the global gastrointestinal OTC drugs market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of various OTC drugs available in the market for the management of gastrointestinal disorders such as:
• GERD/Heartburn
• Constipation
• Diarrhea
• Nausea due to motion sickness
• Flatulence .
Complete Report Details
@ https://www.wiseguyreports.com/reports/46752-global-gastrointestinal-otc-drugs-market-2015-2019
01.
Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market overview
03.2 Product offerings
04. Market Research Methodology
04.1 Market research process
04.2 Research methodology
05. Introduction
06. Overview: OTC Drugs
06.1 Regulatory pathways for OTC approval
06.2 FDA OTC drug approval process
06.2.1 OTC NDA
06.2.2 OTC drug monograph
06.2.3 Gastrointestinal prescription to OTC switch
07. Epidemiology of Gastrointestinal Disorders
08. Market Landscape
08.1 Market overview
08.2 Market size and forecast
08.3 Top predictions
08.4 Five forces analysis
09. Market Segmentation by Therapeutic Class of Drug
09.1.1 Gastric acid reducers
09.1.2 Gastric acid neutralizers
09.1.3 Laxatives
09.1.4 Antidiarrheals
09.1.5 Antiemetics
09.1.6 Others
10. Market Segmentation by Indication
10.1.1 GERD
10.1.2 Constipation
10.1.3 Diarrhea
10.1.4 Nausea caused by motion sickness
10.1.5 Flatulence.
02. List of Abbreviations
03. Scope of the Report
03.1 Market overview
03.2 Product offerings
04. Market Research Methodology
04.1 Market research process
04.2 Research methodology
05. Introduction
06. Overview: OTC Drugs
06.1 Regulatory pathways for OTC approval
06.2 FDA OTC drug approval process
06.2.1 OTC NDA
06.2.2 OTC drug monograph
06.2.3 Gastrointestinal prescription to OTC switch
07. Epidemiology of Gastrointestinal Disorders
08. Market Landscape
08.1 Market overview
08.2 Market size and forecast
08.3 Top predictions
08.4 Five forces analysis
09. Market Segmentation by Therapeutic Class of Drug
09.1.1 Gastric acid reducers
09.1.2 Gastric acid neutralizers
09.1.3 Laxatives
09.1.4 Antidiarrheals
09.1.5 Antiemetics
09.1.6 Others
10. Market Segmentation by Indication
10.1.1 GERD
10.1.2 Constipation
10.1.3 Diarrhea
10.1.4 Nausea caused by motion sickness
10.1.5 Flatulence.
......
Buy This Report@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=46752
Buy This Report@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=46752
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Comments
Post a Comment